Response to “Clinico-mycological and therapeutic updates on cutaneous dermatophytic infections in the era of Trichophyton indotineae”; Focus on griseofulvin - 26/09/24
Doi : 10.1016/j.jaad.2024.06.109
Avrom S. Caplan, MD a, b, ⁎ 
, Sudha Chaturvedi, PhD c, d, Gabrielle Todd, PhD c, Michelle Sikora, BS a, e, Pearl O. Ugwu-Dike, MD a, Vartan Pahalyants, MD, MBA a, Dolly Taiwo, MD a, Jeremy A.W. Gold, MD, MS e, f
, Sudha Chaturvedi, PhD c, d, Gabrielle Todd, PhD c, Michelle Sikora, BS a, e, Pearl O. Ugwu-Dike, MD a, Vartan Pahalyants, MD, MBA a, Dolly Taiwo, MD a, Jeremy A.W. Gold, MD, MS e, f a The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York
b Dermatology Service, Bellevue Hospital Center, New York, New York
c New York State Department of Health, Wadsworth Center Mycology Laboratory, Albany, New York
d Department of Biomedical Sciences, School of Public Health, University at Albany, Albany, New York
e New York Medical College, Valhalla, New York
f Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia
∗Correspondence to: Avrom S. Caplan, MD, The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, 222 East 41st St, 16th Floor, New York, NY 10016The Ronald O. Perelman Department of DermatologyNYU Grossman School of Medicine222 East 41st St16th FloorNew YorkNY10016
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Thursday 26 September 2024
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Key words : antifungal resistance, griseofulvin, itraconazole, terbinafine, topical antifungals, Trichophyton indotineae
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. |
|
| Patient consent: The patient provided written, informed consent to use clinical photographs for publication purposes. Consent is on file with authors. |
|
| IRB approval status: Not applicable. |
|
| Note: This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy (for example, 45 C F R. part 46, 21 C F R. part 56; 42 U S C. §241(d); 5 U S C. §552a; 44 U S C. §3501 et seq). |
© 2024
American Academy of Dermatology, Inc. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?